Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alkermes Plc (NQ: ALKS)
15.83 USD  +0.96 (+6.46%)
Official Closing Price  /  Updated: 4:04 PM EDT, Apr 8, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 957,673
Open 15.07
Bid (Size) 15.82 (1)
Ask (Size) 15.83 (100)
Prev. Close 14.87
Today's Range 14.91 - 16.01
52wk Range 11.98 - 37.75
Shares Outstanding 145,827,889
Dividend Yield N/A
Performance
YTD
-19.89%
-19.89%
1 Month
-9.23%
-9.23%
3 Month
-17.21%
-17.21%
6 Month
-12.35%
-12.35%
1 Year
-57.59%
-57.59%
Top News
More News
Journal of Clinical Psychiatry Publishes Data from Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study of ALKS 3831 in Patients With Schizophrenia
Alkermes plc (Nasdaq: ALKS) today announced the publication of results from the phase 3 ENLIGHTEN-1 clinical trial of ALKS 3831 (olanzapine/samidorphan) in the peer-reviewed publication, Journal of... Read More
from PR Newswire
Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 40th Annual Health Care Conference
Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will present at the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020 at 3:30... Read More
from PR Newswire
More News
Read More
Alkermes to Present at the 9th Annual SVB Leerink Global Healthcare Conference
from PR Newswire
Alkermes Plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2019 and Provides Financial Expectations for 2020
from PR Newswire
Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results
from PR Newswire
Bullish Two Hundred Day Moving Average Cross - ALKS
category Stocks
from Market News Video
Analysts Predict 19% Upside For FBT
category ETFs
from ETF Channel
5-Stock-Sampler Review-a-Palooza
category AMZN , GOOGL , Market News , and 8 more.
from Motley Fool
Alkermes Targets Bipolar Disorder And Schizophrenia
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
Alkermes PLC (ALKS) Q4 2019 Earnings Call Transcript
category ALKS , Market News
from Motley Fool
Here's Why Alkermes Jumped Almost 11% Today
category BIIB , MYL , Market News , and 1 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.